| |
DVT
| |
|---|
|
Variables
|
Yes
|
No
|
p value
|
|---|
| |
(N = 29)
|
(N = 171)
| |
|---|
|
Male sex (F/M)
|
25/4
|
124/47
|
0.12
|
|
ASA score ≥ 3 [no./total no.(%)]
|
13/29(44.8%)
|
61/171(35.7%)
|
0.35
|
|
Age (years)
|
71.0 ± 6.9
|
69.0 ± 7.0
|
0.16
|
|
BMI (kg/m2)
|
26.5 ± 3.9
|
27.8 ± 3.5
|
0.07
|
|
Obesity (BMI ≥ 27, no.)
|
15
|
102
|
0.42
|
|
Pre-operative laboratory data
|
|
Hemoglobin (g/dl)
|
12.6 ± 0.9
|
13.4 ± 1.1
|
< 0.01
|
|
Platelet count (109cells/L)
|
249.2 ± 59.8
|
228.7 ± 55.1
|
0.27
|
|
PT INR
|
1.0 ± 0.04
|
1.0 ± 0.6
|
0.67
|
|
aPTT INR
|
1.0 ± 0.1
|
1.0 ± 0.1
|
0.28
|
|
Types of anesthesia (no.)
| | |
0.61
|
|
General anesthesia
|
25
|
139
| |
|
Spinal anesthesia
|
4
|
32
| |
|
Total blood loss (ml)
|
989.8 ± 300.3
|
1056.6 ± 335.7
|
0.32
|
|
Blood transfusion
|
0/29(0%)
|
8/171(4.7%)
|
0.61
|
- All data are expressed as mean ± standard deviation
- ASA American Society of Anesthesiologists, BMI Body mass index, INR International normalized ratio, PT Prothrombin time, aPTT Activated partial thromboplastin time
